Drug Database
Back to search

Ireland· IE-PA-PA0126/314/002

Galfer 140 mg/5ml Oral Suspension

A ferrous fumarate product containing ferrous fumarate ph.eur., registered in Ireland by Clonmel Healthcare Ltd. The same ATC class is registered in 5 of our 19 countries.

ATC B03AA02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedGalfer 140 mg/5ml Oral SuspensionATCB03AA02REGISTER NO.IE-PA-PA0126/314/002PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ferrous fumarate ph.eur.Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ferrous fumarate is registered in 5 of 19 countries.

Countries holding a registration under ATC B03AA02 (ferrous fumarate), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 2 of them publish a price we can compare per daily dose
Search ferrous fumarate products by name

Ferrous fumarate · ATC B03AA02

5 / 19 countries

  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ferrous fumarate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ferrous fumarate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.62
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Ferrous fumarate Ph.Eur.
Manufacturer
Clonmel Healthcare Ltd
Country
Ireland (IE)
ATC code
B03AA02
ATC class
Ferrous fumarate
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0126/314/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for ferrous fumarate.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ferrous fumarate against other medicinesHow interaction checks work

Ferrous fumarate · interactions on record

89 records

  • 3 severe
  • 69 moderate
  • 7 minor

Most severe, free to view

  • DolutegravirJ05AJ03severe
  • DolutegravirJ05AX12severe
  • DimercaprolV03AB09severe
  • Magnesium carbonateA02AA01moderate

10 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ferrous fumarate in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ferrous fumarate products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Cyprus · Ferrous Fumarate Remedica
  • Germany · Ferrum Hausmann, Rulofer N
  • France · Fumafer
  • United Kingdom (Northern Ireland) · Ferrous Fumarate Kent Pharma Uk, Ferrous Fumarate Mercury Pharma Group Ltd
  • Croatia · Heferol
  • Malta · Ferrous Fumarate
  • Netherlands · Ferrofumaraat Teva, Ferrous Fumarate Aurobindo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2d3cb488-3d60-4a9f-a8a9-5cf5f492d880
GET /v1/drugs/2d3cb488-3d60-4a9f-a8a9-5cf5f492d880?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral suspension",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "B03AA",
    "B03AA02"
  ],
  "strength": null,
  "pa_number": "PA0126/314/002",
  "substances": [
    "Ferrous fumarate Ph.Eur."
  ],
  "legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "25/07/1988",
  "dispensing_status": "Product not subject to medical prescription",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about ferrous fumarate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console